- Research
- Discovery
- Evidence
- Translation
- Clinical Practice
- Human Impact
Vision
Research matters most when it reaches people. This conference follows that journey — from the first data point to evidence that changes care, and from better care to healthier lives.
One day in Riyadh. Eight scientific tracks. One ambition: to turn what we learn into what we do — for patients, families and communities.
Science
Rigorous questions, sound methods and evidence that can be trusted.
People
The patients behind every data point, and the professionals who care for them.
Healthier tomorrows
Knowledge that reaches practice and improves lives across Saudi Arabia.
Welcome Message
It is with great pleasure that I welcome you to the Second Annual Research Conference, a platform where scientific curiosity, collaboration, and discovery come together to shape the future of healthcare.
At King Saud Medical City and Riyadh First Health Cluster, we believe that research is fundamental to advancing healthcare. Every meaningful improvement begins with a question, grows through rigorous scientific inquiry, and reaches its greatest value when evidence is translated into better decisions, better practices, and better outcomes for our patients and communities.
This conference reflects our commitment to empowering researchers, showcasing scientific excellence, strengthening collaboration across disciplines, and creating opportunities for ideas and evidence to move beyond academic discussion into meaningful healthcare impact.
As we build on the success of our previous conference, we look forward to bringing together researchers, clinicians, healthcare professionals, and partners to share knowledge, challenge perspectives, and explore new opportunities for collaboration.
Welcome to a conference where research connects, knowledge advances, and evidence creates impact.
Conference Objectives
Promote a culture of research, innovation, and evidence-based practice across Riyadh First Health Cluster.
Provide a platform for showcasing research, clinical trials, quality improvement initiatives, and healthcare innovation.
Advance clinical research and clinical trial capabilities in alignment with Saudi Vision 2030.
Facilitate scientific collaboration and knowledge exchange among healthcare professionals, researchers, and industry partners.
Strengthen research capacity through education, training, and professional development opportunities.
Recognize excellence in research and innovation while enhancing the academic reputation of King Saud Medical City and Riyadh First Health Cluster.
Scientific Tracks
Eight scientific tracks. One research network.
Every scientific track is a node in the same network — connected by shared questions, methods and patients. Select a scientific track to see its focus.
This track for residents and junior physicians beginning their experience with clinical research.
This track for resident physicians and mid-level researchers wishing to deepen their research skills.
A scientific track aimed at senior researchers and consultants, including systematic reviews and meta-analyses, health technology assessment, research leadership, and applied research.
It includes Good Clinical Practice (GCP), trial phases, regulatory frameworks of the Saudi Food and Drug Authority (SFDA), informed consent, research site management, and pharmacovigilance.
This track encompasses medication use, pharmacovigilance, medication safety, clinical pharmacy research, managing medication lists, patient safety culture, and incident reporting systems.
This includes evidence-based nursing practice, patient care models, nursing outcomes, rehabilitation, physical and occupational therapy, allied health professions innovations, interdisciplinary research collaborations, and staff development.
Covers the surveillance of communicable and non-communicable diseases and related research, health promotion and disease prevention, community health studies, health data analysis, and community interventions.
Focuses on urgent and emergency care, clinical triage and critical assessment, rapid response protocols, and improving care pathways in emergency and urgent care departments.
This track for residents and junior physicians beginning their experience with clinical research.
This track for resident physicians and mid-level researchers wishing to deepen their research skills.
A scientific track aimed at senior researchers and consultants, including systematic reviews and meta-analyses, health technology assessment, research leadership, and applied research.
It includes Good Clinical Practice (GCP), trial phases, regulatory frameworks of the Saudi Food and Drug Authority (SFDA), informed consent, research site management, and pharmacovigilance.
This track encompasses medication use, pharmacovigilance, medication safety, clinical pharmacy research, managing medication lists, patient safety culture, and incident reporting systems.
This includes evidence-based nursing practice, patient care models, nursing outcomes, rehabilitation, physical and occupational therapy, allied health professions innovations, interdisciplinary research collaborations, and staff development.
Covers the surveillance of communicable and non-communicable diseases and related research, health promotion and disease prevention, community health studies, health data analysis, and community interventions.
Focuses on urgent and emergency care, clinical triage and critical assessment, rapid response protocols, and improving care pathways in emergency and urgent care departments.
Scientific Program
08:00 – 08:45
Registration & Welcome Coffee
Delegate registration, badge and pass collection (including judges’ passes), exhibition visit and networking
08:45 – 09:00
Day 1 Briefing
Program overview, housekeeping notes, introduction of the judging panel and evaluation criteria
- Parallel Sessions — Morning
09:00 – 11:30
Health Economics & HTA: Generating Evidence for Value-Based healthcare decision making
- Session Chair
- Fatimah · Hana Abdulkarium · Laila Abu esba
- Discuss pharmacoeconomic modelling approaches and how to strengthen their methodological quality and transparency.
- Explore the role of Health Technology Assessment (HTA) in informing formulary, reimbursement and resource allocation decisions.
- Highlight value-based healthcare approaches, including outcome measurement and linking evidence to value.
- Identify challenges in translating economic research into policy and practice, and ways to bridge the gap between researchers and decision-makers.
09:00 – 11:30
Regulatory Clinical Trials Workshop: Design, Compliance and Quality
- Session Chair
- Doaa · Alaa bakhsh · Omaima Arab
- Review key principles of clinical trial design and methodology, including protocol development, endpoints and sample size considerations.
- Clarify regulatory requirements and approval pathways for clinical trials in Saudi Arabia (SFDA), including submission expectations.
- Apply Good Clinical Practice (GCP) standards to site operations, monitoring and documentation.
- Identify common sources of data quality issues and inspection findings, and how to prevent them.
12:00 – 13:20
Prayer & Lunch Break
Networking and exhibition
- Parallel Sessions — Afternoon
13:20 – 15:00
AI in Healthcare Research: Balancing Innovation, Ethics and Patient Rights
- Session Chair
- Dr.Intisar · Mohammed Alhusnin
- Introduce the key ethical principles guiding the use of AI in healthcare research, including fairness, transparency, accountability and human oversight.
- Discuss patient consent, privacy and data governance for AI-driven research, including secondary use of data and data sharing.
- Review the current and emerging regulatory landscape for AI-enabled tools, including national frameworks (e.g., SDAIA, SFDA, PDPL) and international guidance.
- Highlight the role of ethics committees/IRBs in reviewing AI-based research protocols.
- Share practical recommendations for researchers and institutions to adopt responsible AI practices.
15:00 – 15:20
Day 1 Plenary & Wrap-Up
Key takeaways from each track, announcement of the shortlisted posters, preview of Day 2, and close of Day 1
08:30 – 09:00
Registration & Welcome
Delegate registration, exhibition visit, and networking
09:00 – 10:00
Opening Ceremony
Official inauguration, VIP addresses, and welcome remarks
10:00 – 11:00
Clinical Trials in Saudi Arabia: Building an Integrated Ecosystem from Regulation to Research
Keynote addresses: Clinical Trials in Saudi Arabia
- Moderate
- Dr. Khalid Alsulaiman
- SNIH
- Prof.Majed Aljeraisy
- SFDA
- Omaima Arab
- CRO
- Abdulrahman alshagawi
- Research Center
- Haifa Alotaibi/ Nada/ Dr. Khalid Alamer
- Researcher
- Ahmed Mady or Ahmed Althubiti
- Set the national picture: SNIH to outline the research governance and ethics framework and the national direction for clinical trials.
- Clarify the regulatory pathway: SFDA (Omaima Arab) to explain trial approval requirements and timelines, common submission gaps, and recent initiatives to streamline approvals.
- Show the industry perspective: (Thermo) to share what makes Saudi Arabia attractive for trial placement, plus operational challenges in start-up, feasibility and recruitment.
- Highlight site-level readiness: research center representatives (Haifa Alotabi, Nada, Dr. Khalid Alamer) to discuss infrastructure, capacity, staff training, and how to build competitive, GCP-compliant trial sites.
- Bring the investigator's view: the researcher (Ahmed Mady or Ahmed Althubiti) to reflect on practical barriers, from protocol development and approvals to recruitment and data quality.
- Identify shared bottlenecks and agree on practical solutions that need coordination between regulators, industry, research centers and investigators.
- Close with actionable recommendations to increase the number and quality of locally led and international trials in the Kingdom.
11:00 – 11:20
Coffee Break
Exhibition and poster viewing
11:20 – 12:20
Shaping the Future of Health Research in Saudi Arabia: National Vision and Emerging Trends
Research National Vision and Trends
- Moderate
- Dr. Hisham baderalden
- RDIA
- Ghadir almuhaini
- KEMARIC
- Dr. Nadin almosnid
- Leen
- Hasan Ashmawi
- SNIH
- Prof. Majed Aljeraisy
- Public Health
- Dr. Suliman or Lubna Nasser
- Set the strategic direction: RDIA (Ghadir) to outline national research, development and innovation priorities and how funding is aligned with Vision 2030.
- Show the research-to-impact pathway: KEMARIC (Dr. Nadin) to discuss how research centers translate findings into clinical practice and how to strengthen capacity and infrastructure.
- Highlight digital and industry-enabled research: Leen (Hasan Ashmawi) to share how technology, data and AI are shaping research and where they open new opportunities.
- Present the governance perspective: SNIH (Aljeressi) to discuss ethics oversight, research standards and how to build trust and integrity in the ecosystem.
- Bring the public health lens: Public Health (Dr. Suliman or Lubna Nasser) to explain how population health needs should drive research priorities and how evidence informs policy.
- Identify emerging trends, such as AI, real-world evidence, precision medicine and genomics, and their implications for national research.
- Agree on practical recommendations to align stakeholders, avoid duplication, and build a sustainable, impact-driven research ecosystem.
12:20 – 13:20
Prayer & Lunch Break
Networking and exhibition
13:20 – 13:40
Research & Innovation Center
Keynote addresses: Lunching initiative
13:40 – 14:30
Awards Ceremony
Recognition of all award recipients across all tracks, including the Day 1 poster and presentation winners
14:30 – 15:00
Closing Ceremony
Closing remarks and acknowledgements
08:00 – 08:45
Registration & Welcome Coffee
Delegate registration, badge and pass collection (including judges’ passes), exhibition visit and networking
08:45 – 09:00
Day 1 Briefing
Program overview, housekeeping notes, introduction of the judging panel and evaluation criteria
- Parallel Sessions — Morning
09:00 – 11:30
Health Economics & HTA: Generating Evidence for Value-Based healthcare decision making
- Session Chair
- Fatimah · Hana Abdulkarium · Laila Abu esba
- Discuss pharmacoeconomic modelling approaches and how to strengthen their methodological quality and transparency.
- Explore the role of Health Technology Assessment (HTA) in informing formulary, reimbursement and resource allocation decisions.
- Highlight value-based healthcare approaches, including outcome measurement and linking evidence to value.
- Identify challenges in translating economic research into policy and practice, and ways to bridge the gap between researchers and decision-makers.
09:00 – 11:30
Regulatory Clinical Trials Workshop: Design, Compliance and Quality
- Session Chair
- Doaa · Alaa bakhsh · Omaima Arab
- Review key principles of clinical trial design and methodology, including protocol development, endpoints and sample size considerations.
- Clarify regulatory requirements and approval pathways for clinical trials in Saudi Arabia (SFDA), including submission expectations.
- Apply Good Clinical Practice (GCP) standards to site operations, monitoring and documentation.
- Identify common sources of data quality issues and inspection findings, and how to prevent them.
12:00 – 13:20
Prayer & Lunch Break
Networking and exhibition
- Parallel Sessions — Afternoon
13:20 – 15:00
AI in Healthcare Research: Balancing Innovation, Ethics and Patient Rights
- Session Chair
- Dr.Intisar · Mohammed Alhusnin
- Introduce the key ethical principles guiding the use of AI in healthcare research, including fairness, transparency, accountability and human oversight.
- Discuss patient consent, privacy and data governance for AI-driven research, including secondary use of data and data sharing.
- Review the current and emerging regulatory landscape for AI-enabled tools, including national frameworks (e.g., SDAIA, SFDA, PDPL) and international guidance.
- Highlight the role of ethics committees/IRBs in reviewing AI-based research protocols.
- Share practical recommendations for researchers and institutions to adopt responsible AI practices.
15:00 – 15:20
Day 1 Plenary & Wrap-Up
Key takeaways from each track, announcement of the shortlisted posters, preview of Day 2, and close of Day 1
08:30 – 09:00
Registration & Welcome
Delegate registration, exhibition visit, and networking
09:00 – 10:00
Opening Ceremony
Official inauguration, VIP addresses, and welcome remarks
10:00 – 11:00
Clinical Trials in Saudi Arabia: Building an Integrated Ecosystem from Regulation to Research
Keynote addresses: Clinical Trials in Saudi Arabia
- Moderate
- Dr. Khalid Alsulaiman
- SNIH
- Prof.Majed Aljeraisy
- SFDA
- Omaima Arab
- CRO
- Abdulrahman alshagawi
- Research Center
- Haifa Alotaibi/ Nada/ Dr. Khalid Alamer
- Researcher
- Ahmed Mady or Ahmed Althubiti
- Set the national picture: SNIH to outline the research governance and ethics framework and the national direction for clinical trials.
- Clarify the regulatory pathway: SFDA (Omaima Arab) to explain trial approval requirements and timelines, common submission gaps, and recent initiatives to streamline approvals.
- Show the industry perspective: (Thermo) to share what makes Saudi Arabia attractive for trial placement, plus operational challenges in start-up, feasibility and recruitment.
- Highlight site-level readiness: research center representatives (Haifa Alotabi, Nada, Dr. Khalid Alamer) to discuss infrastructure, capacity, staff training, and how to build competitive, GCP-compliant trial sites.
- Bring the investigator's view: the researcher (Ahmed Mady or Ahmed Althubiti) to reflect on practical barriers, from protocol development and approvals to recruitment and data quality.
- Identify shared bottlenecks and agree on practical solutions that need coordination between regulators, industry, research centers and investigators.
- Close with actionable recommendations to increase the number and quality of locally led and international trials in the Kingdom.
11:00 – 11:20
Coffee Break
Exhibition and poster viewing
11:20 – 12:20
Shaping the Future of Health Research in Saudi Arabia: National Vision and Emerging Trends
Research National Vision and Trends
- Moderate
- Dr. Hisham baderalden
- RDIA
- Ghadir almuhaini
- KEMARIC
- Dr. Nadin almosnid
- Leen
- Hasan Ashmawi
- SNIH
- Prof. Majed Aljeraisy
- Public Health
- Dr. Suliman or Lubna Nasser
- Set the strategic direction: RDIA (Ghadir) to outline national research, development and innovation priorities and how funding is aligned with Vision 2030.
- Show the research-to-impact pathway: KEMARIC (Dr. Nadin) to discuss how research centers translate findings into clinical practice and how to strengthen capacity and infrastructure.
- Highlight digital and industry-enabled research: Leen (Hasan Ashmawi) to share how technology, data and AI are shaping research and where they open new opportunities.
- Present the governance perspective: SNIH (Aljeressi) to discuss ethics oversight, research standards and how to build trust and integrity in the ecosystem.
- Bring the public health lens: Public Health (Dr. Suliman or Lubna Nasser) to explain how population health needs should drive research priorities and how evidence informs policy.
- Identify emerging trends, such as AI, real-world evidence, precision medicine and genomics, and their implications for national research.
- Agree on practical recommendations to align stakeholders, avoid duplication, and build a sustainable, impact-driven research ecosystem.
12:20 – 13:20
Prayer & Lunch Break
Networking and exhibition
13:20 – 13:40
Research & Innovation Center
Keynote addresses: Lunching initiative
13:40 – 14:30
Awards Ceremony
Recognition of all award recipients across all tracks, including the Day 1 poster and presentation winners
14:30 – 15:00
Closing Ceremony
Closing remarks and acknowledgements
Steering Committee
Dr. Mohammed AlMalki
Chief Executive Officer of King Saud Medical City (KSMC) and Executive Director of the Riyadh Health Zone (RHZ)
Dr. Dhafer Mohammed Alahmari
Chief Academic Affairs & Research Officer
Dr. Mashael AlFaifi
Director of the Research & Innovation Center at King Saud Medical City within the Riyadh First Health Cluster
Ms. Jawaher Alkhamisi
Associate, Executive Director for Academic Affairs
Dr. Mubarak Abdulhadi Aldossari
Director of Heart Health Center, Adult Cardiology Department
Dr. Rami Abdullah Alghamdi
Director of Trauma center at King Saud Medical City
Dr. Wael Albalawy
Chief Medical Officer CMO
Dr. Amani Albraiki
Associate Executive Director of Health Services
Mr. Fahad Alnutayfat
Director of Material Management Administration
Mr. Ahmed Abdulaziz Al-Zaaqi
Director of Communication and Change Management at King Saud Medical City (KSMC)
Eng. Mohammed Al-Ghannam
Associate Executive Director of Healthcare Technology, King Saud Medical City
Important Dates
Important dates
Registration Opens
In 3 days
Online Registration Closes
In 54 days
Conference
In 55 days
Add the conference to your calendar
Registration
Registration opens soon
Registration opens 25 September 2026
Online registration will remain open until 15 November 2026.
Opens 25 September 2026
Registration opens in
Venue & Location
Venue & Location
- Venue
- KSMC Hall
- Location
- Riyadh, Saudi Arabia
- Date
- Event
- 2nd Annual Research Conference
- Local time in Riyadh
- ––:––UTC+3